Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-07-26 20:00
Samsung Biologics Reports Second Quarter 2023 Financial Results 2023-07-26 15:23
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023 2023-07-26 00:00
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement 2023-07-25 19:30
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023 2023-07-25 15:19
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial 2023-07-24 21:02
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22 17:50
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND 2023-07-22 00:00
SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979 2023-07-21 22:51
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent 2023-07-21 16:47
Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference 2023-07-21 10:19
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer 2023-07-21 08:15
BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial 2023-07-20 10:41
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech 2023-07-20 09:01
VARON Launches the Game-changer in the Field--New VP Series Portable Oxygen Concentrator with Increased Mobility and Convenience 2023-07-19 22:30
Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA 2023-07-19 21:03
Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication 2023-07-19 10:42
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND 2023-07-19 00:00
Neurophet to unveil brain image analysis technology related to treatment of Alzheimer's disease at AAIC 2023 2023-07-18 21:00
Baird Medical Obtains NMPA Approval of Class III Registered Microwave Ablation Needle for Thyroid Nodules 2023-07-18 20:30
1 69 70 71 72 73 431